Biotech

All Articles

' All hands on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks can easily see the companies putting together tents at basecamp...

Entero giving up team, vacating workplace and also stopping R&ampD

.Mattress Liquidators has transformed Entero Therapeutics white as a sheet. The creditor purchased E...

Exelixis goes down ADC after determining it is actually no suit for Tivdak

.Exelixis is actually surrendering on its tissue variable (TF)- targeting antibody-drug conjugate af...

Relay loses interest in SHP2 inhibitor after Genentech leaves

.3 weeks after Roche's Genentech device left an SHP2 prevention deal, Relay Rehab has actually confi...

Stoke's Dravet disorder med released of partial scientific hold

.Stoke Therapies' Dravet syndrome medicine has been freed from a partial grip, removing the techniqu...

Fierce Biotech's Gabrielle Masson presents Intense 15 at NYSE

.Ferocious Biotech Associate Editor Gabrielle Masson showed the 2024 class of Fierce 15 champions on...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has axed its own once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) growth...

Daiichi pays for Merck $170M to form bronchi cancer cells T-cell engager deal

.Merck &amp Co. has swiftly gotten back a few of the expenses of its Weapon Therapeutics purchase, a...

BioMarin standstills preclinical genetics therapy for heart disease

.After BioMarin carried out a spring clean of its own pipe in April, the provider has actually chose...

Eisai plants molecular adhesive SEED with $1.5 B biobucks work

.Significant Pharmas remain caught to the idea of molecular adhesive degraders. The most recent firm...